Response to the Letter to the Editors by Raschi et al: "Antipsychotics and Drug-Associated Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies"

J Clin Psychopharmacol. 2023 Jan-Feb;43(1):83-84. doi: 10.1097/JCP.0000000000001648.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Antipsychotic Agents* / adverse effects
  • Humans
  • Pharmacovigilance
  • Risk Factors

Substances

  • Antipsychotic Agents